Prednisone Market Players:
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Merck & Co., Inc.
- GSK plc
- Sanofi
- AstraZeneca
- Eli Lilly and Company
- AbbVie Inc.
- Bristol Myers Squibb Company
- F. Hoffmann-La Roche Ltd
- Teva Pharmaceutical Industries Ltd.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of prednisone is assessed at USD 6.91 billion.
The global prednisone market size was valued at around USD 6.6 billion in 2025 and is projected to grow at a CAGR of more than 5.3%, reaching USD 11.06 billion revenue by 2035.
North America is estimated to secure a 35% revenue share in the prednisone market by 2035, fostered by the rising prevalence of asthma in the region.
Key players in the market include Pfizer Inc., Merck & Co., Inc., GSK plc, Sanofi, AstraZeneca, Eli Lilly and Company, AbbVie Inc., Bristol Myers Squibb Company, F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Ltd.
